Carregant...
HbA1c as a predictor for response of bevacizumab in diabetic macular oedema
OBJECTIVE: To study the influence of glycosylated haemoglobin (HbA1c) on response of bevacizumab in patients with diabetic macular oedema. METHODS AND ANALYSIS: A total of 37 eyes of 37 patients with vision loss due to diabetic macular oedema treated with bevacizumab were included in this study. Par...
Guardat en:
| Publicat a: | BMJ Open Ophthalmol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7228525/ https://ncbi.nlm.nih.gov/pubmed/32426522 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjophth-2020-000449 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|